0 Comment
By Mariana González-Márquez | Guadalajara (Mexico) (EFE).- Urologists and oncologists from Latin America have begun to diagnose prostate cancer by identifying biomarkers that allow the creation of personalized medical treatments tailored to each patient. Doctor Miguel Ángel Jiménez Ríos, a surgeon specializing in urology in Mexico, told EFE that these tests at the molecular level... Read More